<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Systems Science: Agent-Based Modeling : Medicine and Health Sciences :" exact="Infectious" post="Diseases : Viral Diseases: Influenza : Research and Analysis"/>
 <result pre="Science: Agent-Based Modeling : Medicine and Health Sciences : Infectious" exact="Diseases" post=": Viral Diseases: Influenza : Research and Analysis Methods:"/>
 <result pre="Modeling : Medicine and Health Sciences : Infectious Diseases :" exact="Viral" post="Diseases: Influenza : Research and Analysis Methods: Simulation and"/>
 <result pre="sciences : Microbiology : Medical microbiology : Microbial pathogens :" exact="Viral" post="pathogens : Orthomyxoviruses : Influenza viruses: Influenza A virus"/>
 <result pre="Pathology and laboratory medicine : Pathogens : Microbial pathogens :" exact="Viral" post="pathogens : Orthomyxoviruses : Influenza viruses: Influenza A virus"/>
 <result pre=": Biology and life sciences : Organisms : Viruses :" exact="Viral" post="pathogens : Orthomyxoviruses : Influenza viruses: Influenza A virus"/>
 <result pre="early work of Bartlett, we define a model with a" exact="limited" post="number of parameters and rates that have clear epidemiological"/>
 <result pre="can be constrained by data. We demonstrate the occurrence of" exact="recurrent" post="behavior in the infected number [more than one peak"/>
 <result pre="dependence on a range of parameter values. Finally, we study" exact="infection" post="with two strains of influenza, inspired by observations, and"/>
 <result pre="first wave of infection. Funding http://dx.doi.org/10.13039/100000060National Institute of Allergy and" exact="Infectious" post="Diseases U19 AI117873 J.W. and C.J. were supported by"/>
 <result pre="wave of infection. Funding http://dx.doi.org/10.13039/100000060National Institute of Allergy and Infectious" exact="Diseases" post="U19 AI117873 J.W. and C.J. were supported by PRIME"/>
 <result pre="can be used to generate all data analyzed here. Introduction" exact="Infectious" post="diseases have been and continue to be a major"/>
 <result pre="the sub-cellular and cellular scales [5]: the outcome of the" exact="infection" post="is determined by the spatio-temporal dynamics of the competition"/>
 <result pre="antagonism. There is a long history of mathematical modeling of" exact="infectious diseases" post="starting from the work of Daniel Bernoulli in the"/>
 <result pre="how agent-based models and stochastic models have been applied to" exact="infectious diseases" post="and their implications for health [9, 10]. A simple"/>
 <result pre="agent-based models to investigate the epidemiology of influenza and other" exact="infectious diseases." post="Watts et al. [14] introduce and study a class"/>
 <result pre="finding behavior with qualitative agreement with features extracted from data." exact="Epidemic" post="processes have been studied in a metapopulation approach with"/>
 <result pre="a stochastic model to argue that seasonal flu leaves a" exact="short" post="refractory period of heterosubtypic immunity which impedes the emergence"/>
 <result pre="network structure of contacts known to determine the spread of" exact="infection" post="(see above) affects the occurrence of recurrences. We analyze,"/>
 <result pre="and numerical simulations to show that recurrences can occur in" exact="measles" post="epidemics on the scale of years when immigration is"/>
 <result pre="Emphasis is on the behavior of the spread of influenza" exact="infection" post="during the course of one flu season, and we"/>
 <result pre="show that the intensity of the second wave of seasonal" exact="infection" post="can be lower with lower inoculation rate for the"/>
 <result pre="intensity of the second wave of seasonal infection can be" exact="lower" post="with lower inoculation rate for the pandemic virus. The"/>
 <result pre="the second wave of seasonal infection can be lower with" exact="lower" post="inoculation rate for the pandemic virus. The rest of"/>
 <result pre="obtained from our model for the case of a two-strain" exact="infection" post="are then discussed. Our results and conclusions are summarized"/>
 <result pre="and methods In early, seminal work in the context of" exact="measles" post="epidemics, Bartlett showed the existence of a critical population"/>
 <result pre="the existence of a critical population size below which the" exact="infection" post="dies off and the occurrence of recurrent behavior if"/>
 <result pre="below which the infection dies off and the occurrence of" exact="recurrent" post="behavior if there is immigration providing a supply of"/>
 <result pre="model [26], a model with s susceptible agents and i" exact="infectious" post="agents, which evolves stochastically in time. Three possible &quot;transitions�?"/>
 <result pre="+ 1 at a rate λ is, recovery, defined by" exact="infectious" post="agents recovering i → i − 1 and becoming"/>
 <result pre="immigration. We seek to explain recurrences (peaks in the reported" exact="infection" post="numbers) on a very different time scale, within one"/>
 <result pre="compared to the interval of 70 weeks or more for" exact="measles" post="[27]) and study the agent-based model described in detail"/>
 <result pre="the first cohort is infected initially, the slow spread of" exact="infection" post="to the second cohort effectively introduces additional susceptible individuals."/>
 <result pre="individuals. This basic feature underlies our agent-based model that displays" exact="recurrent" post="behavior of infected number with substantial stochasticity. We present"/>
 <result pre="allows us to investigate the behavior of the dynamics of" exact="infection" post="in a population as a function of the virulence"/>
 <result pre="correspond to the epidemiological SEIR model: susceptible (S), exposed (E)," exact="infectious" post="(I), and recovered (R). Since it is known from"/>
 <result pre="to reflect the known features of influenza A dynamics. The" exact="primary" post="quantity of interest is the number of infected agents"/>
 <result pre="step of 1 day, which is appropriate for describing influenza" exact="infection" post="in a group of individuals in a single season."/>
 <result pre="time scales, as well as the coarse-grained description of the" exact="infection" post="in our model, we limit our simulations to a"/>
 <result pre="it is common for municipalities to collect data on influenza" exact="infections" post="for this time period, as is the case for"/>
 <result pre="because available immunological data which details the course of influenza" exact="infection" post="for individuals is on the scale of days to"/>
 <result pre="contact matrix, whose elements Cij describe the strength of the" exact="infectious" post="contact between agent i and agent j when one"/>
 <result pre="agent i and agent j when one of them is" exact="infectious" post="and the other susceptible. First, connections within cohorts are"/>
 <result pre="be C0/10. This structure defines a hierarchical model in which" exact="infections" post="generally spread within cohorts, with infections between cohorts happening"/>
 <result pre="hierarchical model in which infections generally spread within cohorts, with" exact="infections" post="between cohorts happening rarely. This separation leads to model"/>
 <result pre="ODE model and ABM. Parameter symbol Meaning Value Reference κ" exact="Infection" post="Time-scale 0.5 days [30] I Time to contagious I"/>
 <result pre="] Varied N Number of agents 6000 Varied E0 Initial" exact="infection" post="size 0.005 ⋅ N kintra Intra-cohort connection degree 16"/>
 <result pre="Varied kbet Inter-cohort connection number 25 Varied βii Intra-cohort ODE" exact="infection" post="rate 2 day−1 βij Inter-cohort ODE infection rate βii/200"/>
 <result pre="βii Intra-cohort ODE infection rate 2 day−1 βij Inter-cohort ODE" exact="infection" post="rate βii/200 ν ODE recovery time 2 days σ"/>
 <result pre="[14] also define a many tiered population structure in which" exact="recurrent" post="influenza infections are shown to occur. The closely connected"/>
 <result pre="define a many tiered population structure in which recurrent influenza" exact="infections" post="are shown to occur. The closely connected contexts in"/>
 <result pre="exposed state; the latter can be viewed as the initial" exact="infection" post="fraction. Each exposed agent remains in the exposed state"/>
 <result pre="end of which the agent makes a transition to the" exact="infectious" post="state. In our model, the duration of I over"/>
 <result pre="In our model, the duration of I over which the" exact="infection" post="is latent is distributed according a uniform distribution between"/>
 <result pre="Upon exiting the latent period, the exposed agent enters the" exact="infectious" post="state. Infectious agents recover in R days after turning"/>
 <result pre="the latent period, the exposed agent enters the infectious state." exact="Infectious" post="agents recover in R days after turning infectious (i.e."/>
 <result pre="infectious state. Infectious agents recover in R days after turning" exact="infectious" post="(i.e. the agent undergoes a transition from the infectious"/>
 <result pre="turning infectious (i.e. the agent undergoes a transition from the" exact="infectious" post="to the recovered state) where R is uniformly distributed"/>
 <result pre="if one adopts the principle of maximum entropy, in the" exact="absence of" post="information (other than the interval of variation), the distribution"/>
 <result pre="that a susceptible agent becomes exposed upon contact with an" exact="infectious" post="agent decreases with increasing Ii. This provides a simple"/>
 <result pre="increase in the mean time to become exposed by an" exact="infectious" post="agent. A fully effective vaccine would extend this mean"/>
 <result pre="lack of data on individual variation in immunological profile. Each" exact="infectious" post="agent j is characterized by a parameter, Vj, which"/>
 <result pre="which represents the infectivity of the individual j in the" exact="infectious" post="state. It is clearly insufficient to characterize infectivity by"/>
 <result pre="a single parameter since it encompasses the relative rate of" exact="viral" post="shedding, personal hygiene, and many other parameters that vary"/>
 <result pre="is simply characterized by the state (E) until they turn" exact="infectious" post="at the end of the period I i ,"/>
 <result pre="above. Susceptible agents are dynamically inert until their contact with" exact="infectious" post="agents gives them a probabilistic rate to become exposed"/>
 <result pre="Cij is the contact matrix connecting susceptible individual i to" exact="infectious" post="individual j, Vj is the infectivity of individual j,"/>
 <result pre="Vj is the infectivity of individual j, J is the" exact="total" post="number of infectious agents connected to the susceptible agent"/>
 <result pre="infectivity of individual j, J is the total number of" exact="infectious" post="agents connected to the susceptible agent i under consideration,"/>
 <result pre="Cij &amp;gt; 0 (there is contact) and the agent is" exact="infectious" post="(Vj &amp;gt; 0). The tunable parameter κ is time-independent,"/>
 <result pre="κ is time-independent, and sets the time scale on which" exact="infection" post="is transmitted: it determines the range of values of"/>
 <result pre="the probability should increase with the number of contacts with" exact="infectious" post="agents and their infectivities. Our choice makes this linearly"/>
 <result pre="the period for which the agent remains infectious, and the" exact="infectious" post="parameter Vi during the period of infectivity. These values"/>
 <result pre="remaining agents are checked for their possible transitions: exposed becoming" exact="infectious" post="or infectious becoming recovered if the time elapsed after"/>
 <result pre="are checked for their possible transitions: exposed becoming infectious or" exact="infectious" post="becoming recovered if the time elapsed after they become"/>
 <result pre="recovered if the time elapsed after they become exposed or" exact="infectious" post="exceeds their assigned durations { I } and {"/>
 <result pre="2), which are respectively, the fraction of susceptible, exposed, and" exact="infectious" post="individuals in cohort j at time t. The differential"/>
 <result pre="because susceptible agents become exposed due to contact with the" exact="infectious" post="fraction I1 in cohort 1, and also decreasing due"/>
 <result pre="The exposed fraction in a cohort turns over to the" exact="infectious" post="fraction at a rate σ; the infectious fraction recovers"/>
 <result pre="over to the infectious fraction at a rate σ; the" exact="infectious" post="fraction recovers at a rate ν and has no"/>
 <result pre="as discussed later. The results of the simulation for the" exact="total" post="infected number I(t) = I1(t) + I2(t) + E1(t)"/>
 <result pre="the cohort. The time for the exposed fraction to become" exact="infectious" post="1/σ = 2 days, and the recovery time of"/>
 <result pre="1/σ = 2 days, and the recovery time of the" exact="infectious" post="fraction 1/ν = 2 days are close to those"/>
 <result pre="to those in the agent-based model discussed above. Fig 2" exact="Total" post="infected (sum of exposed and infectious agents) number as"/>
 <result pre="discussed above. Fig 2 Total infected (sum of exposed and" exact="infectious" post="agents) number as a function of time for two-cohort"/>
 <result pre="and the recovery rate ν is 0.10. The separation in" exact="infection" post="timescale between intra-cohort spread and inter-cohort spread leads to"/>
 <result pre="in the infected number. This peak separation decreases if the" exact="infection" post="rates are made closer in value, as well if"/>
 <result pre="cohort is exposed initially, we find two peaks in the" exact="total" post="infected fraction as a function of time as shown"/>
 <result pre="Fig 2. We have normalized the fractions so that the" exact="total" post="in each cohort is unity. In contrast, in the"/>
 <result pre="as a function of time. As the separation of the" exact="infection" post="time scales is reduced by increasing β12, the time"/>
 <result pre="so that while the susceptible population fraction decreased instantaneously upon" exact="infection" post="at time t, the infected numbers increase only after"/>
 <result pre="insights into the dynamics of the spread of infection. The" exact="primary" post="quantity of interest is the time evolution of the"/>
 <result pre="infected agents (the sum of the number of exposed and" exact="infectious" post="agents at a given time) given a small number"/>
 <result pre="above demonstrates that in a deterministic system, we can find" exact="recurrent" post="behavior; here, we study the stochastic behavior in the"/>
 <result pre="the discrete ABM with a finite number of agents, a" exact="limited" post="number of contacts, and probabilistic time evolution. We investigate"/>
 <result pre="to 4. We note that the rate at which the" exact="infection" post="spreads decreases exponentially with the immunization strength. The different"/>
 <result pre="as the sum of the number of exposed agents and" exact="infectious" post="agents at a given time. While it is difficult"/>
 <result pre="We have verified that the number of agents in the" exact="infectious" post="(i.e. contagious) state exhibits similar behavior. We display the"/>
 <result pre="as is evident from the figure. The value of the" exact="infection" post="number at the peaks are much higher, as would"/>
 <result pre="of immunity leads to time scales for the rate of" exact="infection" post="transmission between individuals comparable to or faster to the"/>
 <result pre="to or faster to the time duration before which an" exact="infectious" post="individual recovers. However, the inter-cohort spread, through the weak,"/>
 <result pre="infectious individual recovers. However, the inter-cohort spread, through the weak," exact="intermediate" post="connections, is slow and the position of the peaks"/>
 <result pre="immunity leads to slow time scales for the rate of" exact="infection" post="transmission between individuals compared to the duration before which"/>
 <result pre="transmission between individuals compared to the duration before which an" exact="infectious" post="individual recovers. The inter-cohort spread, through the weak, intermediate"/>
 <result pre="an infectious individual recovers. The inter-cohort spread, through the weak," exact="intermediate" post="connections, is slower still and so we see an"/>
 <result pre="so we see an overall decay of the number of" exact="infectious" post="agents. One sees smaller peaks punctuating the overall decline"/>
 <result pre="in which the population possesses a strong immune profile, the" exact="secondary" post="peaks are not well-defined. In fact, the time course"/>
 <result pre="roughly 7 (≈e2). The combination of fewer susceptible agents and" exact="lower" post="probability for transitions means that new infections are relatively"/>
 <result pre="susceptible agents and lower probability for transitions means that new" exact="infections" post="are relatively rare events. Since only a small number"/>
 <result pre="relatively rare events. Since only a small number of new" exact="infectious" post="occurs across the cohort in a short time interval,"/>
 <result pre="number of new infectious occurs across the cohort in a" exact="short" post="time interval, the fluctuations are large and this makes"/>
 <result pre="on the right. For a population with weak immune strength," exact="infection" post="spreads rapidly throughout the initial cohort, leading to a"/>
 <result pre="availability of fewer susceptible agents, leading to many pauses in" exact="infection" post="spread throughout the cohort. The histograms each represent 10,000"/>
 <result pre="case. The introduction of a stronger immune response forces the" exact="infection" post="to spread through relatively rare events as discussed earlier."/>
 <result pre="the values center around P ∼ 10−3. This means that" exact="infection" post="spread is unlikely, even on the scale of the"/>
 <result pre="with low probability: we focus on the spread of the" exact="infection" post="across cohorts; in particular, the time at which the"/>
 <result pre="the weak immune case, and examine the first incidence of" exact="infection" post="in the second cohort. The results are shown in"/>
 <result pre="We see that the distribution of times of first successful" exact="infection" post="in the second cohort is very broad, despite the"/>
 <result pre="becoming infected. Typically, the small number of intra-cohort connections necessitates" exact="infection" post="of a large fraction of the cohort before those"/>
 <result pre="to the next cohort are infected. Since the probability of" exact="infection" post="rarely rises above 0.1 for the parameters we have"/>
 <result pre="Fig 6 Distributions displaying the occurrence time of the first" exact="infection" post="in the second cohort for weak immune strength. The"/>
 <result pre="sparsely connected structure displays a very wide distribution of first" exact="infection" post="times, despite rapid intra-cohort spread as shown in Fig"/>
 <result pre="Fig 6, we see that the distribution of second cohort" exact="infection" post="times both shifts earlier in time, as well as"/>
 <result pre="5, as the mean timing of the second cohort’s first" exact="infection" post="is coincident with the timing of the mean first"/>
 <result pre="the timing of the mean first peak occurrence. The rapid" exact="infection" post="spread statistically reaches both more agents which have connections"/>
 <result pre="in spread between weakly connected subpopulations. The distribution of first" exact="infection" post="times in the second cohort in the strong immune"/>
 <result pre="noted that a large fraction of the samples shows no" exact="infection" post="in the second cohort within one season due to"/>
 <result pre="completeness. See S6 Fig. Another feature which characterizes the stochastic" exact="infection" post="spread is the timing of the second peak of"/>
 <result pre="the probability and the time of additional increases in the" exact="infection" post="after the first peak, or recurrences, is of practical"/>
 <result pre="the time interval between the first and second wave of" exact="infection" post="in this model in the weak immune case. The"/>
 <result pre="it takes longer for the first cohort to have many" exact="infections" post="in the case of a strong immune defense as"/>
 <result pre="as seen in Fig 4. Given the bottleneck for the" exact="infection" post="to spread to the second cohort, the second peak"/>
 <result pre="immune strength causes wide fluctuations in the time course of" exact="infection" post="events. The histogram is constructed out of 10,000 sample"/>
 <result pre="reproductive number as the number of susceptible agents that an" exact="infectious" post="individual infects during the time before recovery averaged over"/>
 <result pre="as follows: we count the change in the number of" exact="infectious" post="people from one day to the next. We divide"/>
 <result pre="next. We divide this number by the original number of" exact="infectious" post="people from the previous day. This is an attempt"/>
 <result pre="field data, in which only the people who are visibly" exact="symptomatic" post="are likely to report to a hospital. We relate"/>
 <result pre="through a reduction in the reproduction number, and (b) of" exact="recurrent" post="infection waves, seen through the elimination of the second"/>
 <result pre="a reduction in the reproduction number, and (b) of recurrent" exact="infection" post="waves, seen through the elimination of the second interval"/>
 <result pre="First, we analyze how the model results depend on the" exact="total" post="size of the population. This is an important consideration"/>
 <result pre="qualitative features of the model remain approximately unchanged as the" exact="total" post="population number is increased. In Fig 9, we show"/>
 <result pre="becoming a discernible second peak at N = 8000. For" exact="lower" post="values of N, the number of infectious people can"/>
 <result pre="= 8000. For lower values of N, the number of" exact="infectious" post="people can easily fluctuate down to 0, prematurely ending"/>
 <result pre="numbers of agents, a stochastic fluctuation is less likely to" exact="collapse" post="the run, leading to more opportunities for spread, and"/>
 <result pre="infectious) people as a function of time for four different" exact="total" post="population sizes, all with the parameters given in Table"/>
 <result pre="For low values of N, (1000 and 2000), stochastic population" exact="collapse" post="occurs frequently enough that there is only one well-defined"/>
 <result pre="in biological models [46, 47]. Recurrences occur and are relatively" exact="stable" post="for values of N greater than 4000, continuing up"/>
 <result pre="matrix element and other parameters unchanged. We see that at" exact="lower" post="values of the connectivity, the peaks are separated on"/>
 <result pre="infectious. This rate depends on the speed with which the" exact="infection" post="spreads within an individual cohort, and this time decreases"/>
 <result pre="cohort connectivity. This is seen in Fig 10. Fig 10" exact="Infectious" post="number as a function of time in several sample"/>
 <result pre="infected individuals in the first cohort of 4 in a" exact="total" post="population of 6000. The significant change is in the"/>
 <result pre="easy to see that there is a bottleneck for the" exact="infection" post="to spread between cohorts. However, increasing the number of"/>
 <result pre="preceding are connected decreases the period of time for the" exact="infection" post="to spread between cohorts. This washes out the well-separated"/>
 <result pre="the connection degree is increased, we recover the single-cohort SIR-like" exact="infection" post="curve in which there is one large period of"/>
 <result pre="intra-cohort transmission rates become comparable, we obtain a single large" exact="infection" post="peak as in the one cohort SEIR model. As"/>
 <result pre="into well-separated segments, we obtain well-defined recurrence peaks corresponding to" exact="infection" post="spreading into the successive cohorts. Two strains In the"/>
 <result pre="replication of the H3N2 was decreased in comparison with single" exact="infection" post="by H3N2. Thus, there is microscopic evidence for the"/>
 <result pre="of the immune response to the first strain on the" exact="infection" post="by the second strain: it provides protection against it."/>
 <result pre="into the parameters of the macroscopic model, we assume that" exact="infection" post="with the first virus (pandemic) provides increased immunity to"/>
 <result pre="strains in the model, i.e. the distributions of Vi of" exact="infectious" post="individuals was kept the same in the absence of"/>
 <result pre="Vi of infectious individuals was kept the same in the" exact="absence of" post="clear data to the contrary. Immunization against the pandemic"/>
 <result pre="inoculated. This implies an enhancement of the fundamental timescale of" exact="infection" post="of inoculated individuals by at least a factor of"/>
 <result pre="rate. We used a model with four cohorts, and a" exact="total" post="population of N = 6000. The key results for"/>
 <result pre="= 6000. The key results for the mean number of" exact="infections" post="of the two strains as a function of time"/>
 <result pre="there is a first peak that corresponds to the initial" exact="infection" post="due to the pandemic strain. The vaccine effectiveness over"/>
 <result pre="However, this prevention is compensated by a large wave of" exact="infection" post="in the seasonal strain; the number of peak cases"/>
 <result pre="the number of peak cases is twice that of the" exact="lower" post="inoculation rate. This feature is examined in the main"/>
 <result pre="are infected by the first virus (more likely with the" exact="lower" post="inoculation rate), then they cannot be infected by the"/>
 <result pre="the increase in stochasticity of the occurrence of the seasonal" exact="infection" post="seen in the curves in the lower right panel"/>
 <result pre="of the seasonal infection seen in the curves in the" exact="lower" post="right panel of S9 Fig; this is a result"/>
 <result pre="out a possible mechanism that can yield an increase the" exact="infection" post="number for the second strain when vaccination rate for"/>
 <result pre="The left panel shows the probability of a given maximum" exact="infection" post="level for the case with no immunization against the"/>
 <result pre="infected with the seasonal strain compared to the pandemic strain" exact="infections" post="in both cases, the contrast is clear. The maximum"/>
 <result pre="a larger fraction of the population is protected from pandemic" exact="infection" post="for higher immunization, they are more susceptible to the"/>
 <result pre="weakly connected, we obtain increasingly better-defined recurrence peaks corresponding to" exact="infection" post="spreading into the successive cohorts. We examined the stochastic"/>
 <result pre="transmissibilty between cohorts of populations, leading to opportunistic spread of" exact="infection" post="from one cohort to another give rise to recurrences"/>
 <result pre="randomly. Within a cohort whose members are well-immunized, although the" exact="infectious" post="number is limited, the times at which the peak"/>
 <result pre="revealed that immunity induced by inoculation against one strain of" exact="infection" post="can lead to increased occurrence of a second later"/>
 <result pre="delay. There is a delay inserted between the time of" exact="infection" post="and the transition of the susceptible number to infected."/>
 <result pre="is solved with the initial conditions of 0.5% of the" exact="total" post="population in the first cohort infected, with the remaining"/>
 <result pre="Fig Histogram of the number of peaks found in the" exact="infection" post="time course over 1000 runs of the case of"/>
 <result pre="Fig Histogram of the number of peaks found in the" exact="infection" post="time course over 1000 runs of the case of"/>
 <result pre="case with a population size of 20,000. We see clear," exact="stable" post="recurrences, in accordance with the large N behavior shown"/>
 <result pre="connection strength is not scaled (see Fig 11), we retain" exact="stable" post="recurrences throughout the increase in inter-cohort connectivity. (TIF) LINK"/>
 <result pre="additional data file. S6 Fig Histogram of incidence of first" exact="infection" post="in the second cohort for a strong immune response."/>
 <result pre="separated for low connection degree become smoothed into one larger" exact="infection" post="peak as the degree is progressively increased. Since this"/>
 <result pre="corresponding parameters is shown in Fig 12. As expected, with" exact="lower" post="levels of immunization, the number of people infected with"/>
 <result pre="with pandemic flu increases. However, we observe the suppression of" exact="infection" post="recurrences in the seasonal strain for lower levels of"/>
 <result pre="the suppression of infection recurrences in the seasonal strain for" exact="lower" post="levels of vaccination against the pandemic strain (b). In"/>
 <result pre="vaccination against the pandemic strain (b). In contrast, in the" exact="lower" post="right panel for the higher rate of inoculation for"/>
 <result pre="as a result of the immunity to the second, seasonal" exact="infection" post="conferred by being infected earlier by first pandemic strain"/>
 <result pre="for aid in preparation of the manuscript. References References 1BrachmanPS." exact="Infectious" post="diseases—past, present, and future. International Journal of Epidemiology. 2003;32(5):684–686."/>
 <result pre="and future. International Journal of Epidemiology. 2003;32(5):684–686. 10.1093/ije/dyg28214559728 2FonkwoPN. Pricing" exact="infectious disease." post="EMBO reports. 2008;9(S1):S13–S17. 10.1038/embor.2008.11018578017 3IulianoAD, RoguskiKM, ChangHH, MuscatelloDJ, PalekarR,"/>
 <result pre="ChangHH, MuscatelloDJ, PalekarR, TempiaS, et al.Estimates of global seasonal influenza-associated" exact="respiratory" post="mortality: a modelling study. The Lancet. 2018;391(10127):1285–1300. 10.1016/S0140-6736(17)33293-2 4TokarsJI,"/>
 <result pre="Seasonal Incidence of Symptomatic Influenza in the United States. Clinical" exact="Infectious" post="Diseases. 2017;66(10):1511–1518. 10.1093/cid/cix1060 5CainiS, KronemanM, WiegersT, El Guerche-SéblainC, PagetJ."/>
 <result pre="WiegersT, El Guerche-SéblainC, PagetJ. Clinical characteristics and severity of influenza" exact="infections" post="by virus type, subtype, and lineage: A systematic literature"/>
 <result pre="subtype, and lineage: A systematic literature review. Influenza and Other" exact="Respiratory" post="Viruses. 2018;12(6):780–792. 10.1111/irv.1257529858537 6KermackWO, McKendrickAG, WalkerGT. A contribution to"/>
 <result pre="of a Mathematical and Physical Character. 1927;115(772):700–721. 7KeelingMJ, RohaniP. Modeling" exact="infectious diseases" post="in humans and animals. Princeton University Press; 2008. 8KilbourneED."/>
 <result pre="Press; 2008. 8KilbourneED. Influenza pandemics of the 20th century. Emerging" exact="infectious diseases." post="2006;12(1):9–14. 10.3201/eid1201.05125416494710 9VenkatramananS, LewisB, ChenJ, HigdonD, VullikantiA, MaratheM. Using"/>
 <result pre="HigdonD, VullikantiA, MaratheM. Using data-driven agent-based models for forecasting emerging" exact="infectious diseases." post="Epidemics. 2018;22:43—49. 10.1016/j.epidem.2017.02.01028256420 10ChaoDL, HalloranME, ObenchainVJ, LonginiIMJr. FluTE, a"/>
 <result pre="10ChaoDL, HalloranME, ObenchainVJ, LonginiIMJr. FluTE, a Publicly Available Stochastic Influenza" exact="Epidemic" post="Simulation Model. PLOS Computational Biology. 2010;6(1):1–8. 10.1371/journal.pcbi.1000656 11BartlettMS. Stochastic"/>
 <result pre="Reports. 2019;9(1):231510.1038/s41598-019-38722-430783178 16TanakaG, UrabeC, AiharaK. Random and Targeted Interventions for" exact="Epidemic" post="Control in Metapopulation Models. Scientific Reports. 2014;4(1):552210.1038/srep0552225026972 17GuoD, LiKC,"/>
 <result pre="al.Containing Pandemic Influenza at the Source. Science. 2005;309(5737):1083–1087. 10.1126/science.111571716079251 21for" exact="Disease" post="Control C, Prevention. Weekly U.S. Influenza Surveillance Report; 2019."/>
 <result pre="Columbus Flu Reports. Influenza Surveillance. 2019. Available from: https://www.columbus.gov/Weekly_Flu_Update/. 24for" exact="Disease" post="Control C, Prevention. Influenza Information. Centers for Disease Control"/>
 <result pre="https://www.columbus.gov/Weekly_Flu_Update/. 24for Disease Control C, Prevention. Influenza Information. Centers for" exact="Disease" post="Control and Prevention. 2018. Available from: https://www.cdc.gov/flu/about/disease/spread.htm. 25Bartlett MS."/>
 <result pre="Available from: https://www.cdc.gov/flu/about/disease/spread.htm. 25Bartlett MS. Deterministic and Stochastic Models for" exact="Recurrent" post="Epidemics. In: Proceedings of the Third Berkeley Symposium on"/>
 <result pre="81–109. Available from: https://projecteuclid.org/euclid.bsmsp/1200502549. 26SoperHE. The Interpretation of Periodicity in" exact="Disease" post="Prevalence. Journal of the Royal Statistical Society. 1929;92(1):34–73. 10.2307/2341437"/>
 <result pre="10.2307/2342553 28LesslerJ, ReichNG, BrookmeyerR, PerlTM, NelsonKE, CummingsDA. Incubation periods of" exact="acute" post="respiratory viral infections: a systematic review. The Lancet Infectious"/>
 <result pre="28LesslerJ, ReichNG, BrookmeyerR, PerlTM, NelsonKE, CummingsDA. Incubation periods of acute" exact="respiratory" post="viral infections: a systematic review. The Lancet Infectious Diseases."/>
 <result pre="ReichNG, BrookmeyerR, PerlTM, NelsonKE, CummingsDA. Incubation periods of acute respiratory" exact="viral" post="infections: a systematic review. The Lancet Infectious Diseases. 2009;9(5):291–300."/>
 <result pre="of acute respiratory viral infections: a systematic review. The Lancet" exact="Infectious" post="Diseases. 2009;9(5):291–300. 10.1016/S1473-3099(09)70069-619393959 29SanjuánR, NebotMR, ChiricoN, ManskyLM, BelshawR. Viral"/>
 <result pre="Lancet Infectious Diseases. 2009;9(5):291–300. 10.1016/S1473-3099(09)70069-619393959 29SanjuánR, NebotMR, ChiricoN, ManskyLM, BelshawR." exact="Viral" post="Mutation Rates. Journal of Virology. 2010;84(19):9733–9748. 10.1128/JVI.00694-1020660197 30LukensS, DePasseJ,"/>
 <result pre="al.Mapping a social network of heterosexuals at high risk for" exact="HIV infection." post="AIDS. 1994;8(9):1331–1336. 10.1097/00002030-199409000-000187802989 32WYLIEJL, JOLLYA. Patterns of Chlamydia and"/>
 <result pre="AIDS. 1994;8(9):1331–1336. 10.1097/00002030-199409000-000187802989 32WYLIEJL, JOLLYA. Patterns of Chlamydia and Gonorrhea" exact="Infection" post="in Sexual Networks in Manitoba, Canada. Sexually Transmitted Diseases."/>
 <result pre="File J ThomasM, FryAM, et al.Clinical Practice Guidelines by the" exact="Infectious" post="Diseases Society of America: 2018 Update on Diagnosis, Treatment,"/>
 <result pre="J ThomasM, FryAM, et al.Clinical Practice Guidelines by the Infectious" exact="Diseases" post="Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis,"/>
 <result pre="Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clinical" exact="Infectious" post="Diseases. 2018;68(6):e1–e47. 10.1093/cid/ciy866 36PulendranB, LiS, NakayaHI. Systems Vaccinology. Immunity."/>
 <result pre="43CarratF, VerguE, FergusonNM, LemaitreM, CauchemezS, LeachS, et al.Time Lines of" exact="Infection" post="and Disease in Human Influenza: A Review of Volunteer"/>
 <result pre="FergusonNM, LemaitreM, CauchemezS, LeachS, et al.Time Lines of Infection and" exact="Disease" post="in Human Influenza: A Review of Volunteer Challenge Studies."/>
 <result pre="Disease in Human Influenza: A Review of Volunteer Challenge Studies." exact="American" post="Journal of Epidemiology. 2008;167(7):775–785. 10.1093/aje/kwm37518230677 44BernsteinSL, AronskyD, DusejaR, EpsteinS,"/>
 <result pre="immune response to influenza virus at single-cell resolution in human" exact="epithelial" post="cells revealed paracrine induction of interferon lambda 1. Journal"/>
 <result pre="of interferon lambda 1. Journal of Virology. 2019;. 10.1128/JVI.00559-19 49for" exact="Disease" post="Control C. CDC Sortable Stats. CDC Published Data. 2019."/>
</results>
